APA

Lim J. S. L., Chen X. A., Singh O., Yap Y. S., Ng R. C. H., Wong N. S., Wong M., Lee E. J. D. & Chowbay B. (20110628). Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. : British journal of clinical pharmacology.

Chicago

Lim Joanne S L, Chen Xiang A, Singh Onkar, Yap Yoon S, Ng Raymond C H, Wong Nan S, Wong Mabel, Lee Edmund J D and Chowbay Balram. 20110628. Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. : British journal of clinical pharmacology.

Harvard

Lim J. S. L., Chen X. A., Singh O., Yap Y. S., Ng R. C. H., Wong N. S., Wong M., Lee E. J. D. and Chowbay B. (20110628). Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. : British journal of clinical pharmacology.

MLA

Lim Joanne S L, Chen Xiang A, Singh Onkar, Yap Yoon S, Ng Raymond C H, Wong Nan S, Wong Mabel, Lee Edmund J D and Chowbay Balram. Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. : British journal of clinical pharmacology. 20110628.